Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study
Author | AbouGalala, Khalid |
Author | Elsayed, Basant |
Author | Elmarasi, Mohamed |
Author | Kotob, Mona |
Author | Taha, Reham |
Author | Abbasher, Fardous |
Author | Amarah, Ahmed |
Author | El Hamawi, Mariam |
Author | Albayat, Soha S. |
Author | Abdulmajeed, Jazeel |
Author | Sallam, Mohamed A.H. |
Author | Al-Shamali, Maha H.M. |
Author | Al-Romaihi, Hamad E. |
Author | Bansal, Devendra |
Author | Musa, Omran A.H. |
Author | Farag, Elmoubasher |
Author | Al-Thani, Mohammed H.J. |
Author | Chivese, Tawanda |
Author | Emara, Mohamed M. |
Available date | 2023-05-03T09:45:09Z |
Publication Date | 2023-02-20 |
Publication Name | Microbiology Research |
Identifier | http://dx.doi.org/10.3390/microbiolres14010023 |
Citation | AbouGalala, K., Elsayed, B., Elmarasi, M., Kotob, M., Taha, R., Abbasher, F., ... & Emara, M. M. (2023). Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study. Microbiology Research, 14(1), 289-296. |
ISSN | 2036-7473 |
Abstract | This study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar. |
Language | en |
Publisher | PagePress |
Subject | chronic diseases comorbidities COVID-19 Middle East and North Africa mortality multimorbidity pre-existing diseases SARS-CoV-2 |
Type | Article |
Pagination | 289-296 |
Issue Number | 1 |
Volume Number | 14 |
ESSN | 2036-7481 |
Files in this item
This item appears in the following Collection(s)
-
COVID-19 Research [835 items ]
-
Medicine Research [1509 items ]